{
    "2020-05-14": [
        [
            {
                "time": "",
                "orginal_text": "家公司重要股东减持金额超亿元",
                "features": {
                    "keywords": [
                        "重要股东",
                        "减持",
                        "金额超亿元"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "狂砸27亿！“牛股收割机”高瓴又出手了",
                "features": {
                    "keywords": [
                        "高瓴",
                        "出手",
                        "27亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "高瓴资本再次开启A股买买买节奏还承诺带来8亿元订单",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "A股",
                        "买买买",
                        "8亿元订单"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "44.33亿元资金今日流出医药生物股",
                "features": {
                    "keywords": [
                        "资金流出",
                        "医药生物",
                        "44.33亿元"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "公募权益类基金2020年一季报持仓分析：仓位小幅下调 医药基建TMT三大板块受关注",
                "features": {
                    "keywords": [
                        "公募基金",
                        "2020年一季报",
                        "医药",
                        "基建",
                        "TMT"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基建",
                        "TMT"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "生物制品-2020年M1-M4疫苗批签发报告：重点疫苗品种批签发整体同比表现强劲 国产大品种时代开启",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "国产大品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "等权重医药100，为何能跑赢大多数医药指数？",
                "features": {
                    "keywords": [
                        "医药100",
                        "跑赢",
                        "指数"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "高瓴再次出手增持凯利泰，爱上医疗停不下来",
                "features": {
                    "keywords": [
                        "高瓴",
                        "增持",
                        "凯利泰",
                        "医疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "这六只医药主题基金必须要收藏 前十大重仓股都有这些",
                "features": {
                    "keywords": [
                        "医药主题基金",
                        "重仓股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "被传创纪录募资130亿美元后，高瓴再次强势出手，这次还拉上了淡马锡",
                "features": {
                    "keywords": [
                        "高瓴",
                        "募资",
                        "130亿美元",
                        "淡马锡"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "不惧高估值 金牛私募与北向资金紧盯二线白马",
                "features": {
                    "keywords": [
                        "高估值",
                        "金牛私募",
                        "北向资金",
                        "二线白马"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "两路聪明钱操作截然相反：ETF全线撤退，北向资金买买买",
                "features": {
                    "keywords": [
                        "聪明钱",
                        "ETF",
                        "撤退",
                        "北向资金",
                        "买买买"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "最高涨四成！医药基金业绩炸裂 哪些医药股是“心头好”？",
                "features": {
                    "keywords": [
                        "医药基金",
                        "业绩炸裂",
                        "医药股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "“核心资产”迭创新高 北向资金“喝酒吃药”上瘾",
                "features": {
                    "keywords": [
                        "核心资产",
                        "北向资金",
                        "喝酒吃药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "不惧高估值看好结构牛 金牛私募与北向资金紧盯二线白马",
                "features": {
                    "keywords": [
                        "高估值",
                        "结构牛",
                        "金牛私募",
                        "北向资金",
                        "二线白马"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}